We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
+3.48%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$942M
AUM Growth
+$47.5M
Cap. Flow
+$57.7M
Cap. Flow %
6.13%
Top 10 Hldgs %
36.92%
Holding
174
New
107
Increased
33
Reduced
23
Closed
6

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$22.8M
2
FOLD
Amicus Therapeutics
FOLD
+$16.4M
3
COLL icon
Collegium Pharmaceutical
COLL
+$15.5M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$13.7M
5
AERI
Aerie Pharmaceuticals
AERI
+$10.4M

Top Sells

Rank Stock Value
1
SRPT icon
Sarepta Therapeutics
SRPT
+$24.4M
2
MOH icon
Molina Healthcare
MOH
+$17.5M
3
EXAS
Exact Sciences
EXAS
+$14.2M
4
PRAH
PRA Health Sciences, Inc.
PRAH
+$13.9M
5
ALXN
Alexion Pharmaceuticals
ALXN
+$11.5M

Sector Composition

Rank Sector Weight
1 Healthcare 84.63%
2 Industrials 0.89%
3 Technology 0.84%
4 Financials 0.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ECYT
126
DELISTED
Endocyte, Inc. Common Stock
ECYT
$233K 0.02%
+13,141
New +$226K
AET
127
DELISTED
Aetna Inc
AET
$232K 0.02%
+1,143
New +$223K
CCXI
128
DELISTED
ChemoCentryx, Inc.
CCXI
$225K 0.02%
+17,811
New +$215K
TEVA icon
129
Teva Pharmaceuticals
TEVA
$40.4B
$218K 0.02%
+10,120
New +$235K
BLRX
130
BioLineRX
BLRX
$12M
$212K 0.02%
+330
New +$182K
NUVA
131
DELISTED
NuVasive, Inc.
NUVA
$211K 0.02%
+2,975
New +$189K
KANG
132
DELISTED
iKang Healthcare Group, Inc.
KANG
$208K 0.02%
+11,513
New +$222K
KURA icon
133
Kura Oncology
KURA
$793M
$207K 0.02%
+11,800
New +$226K
GTHX
134
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$202K 0.02%
+3,857
New +$210K
AMRX icon
135
Amneal Pharmaceuticals
AMRX
$6.1B
$201K 0.02%
+9,040
New +$190K
IMGN
136
DELISTED
Immunogen Inc
IMGN
$199K 0.02%
+21,013
New +$202K
OSUR icon
137
OraSure Technologies
OSUR
$273M
$195K 0.02%
+12,609
New +$207K
FPRX
138
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$194K 0.02%
+13,920
New +$207K
LITS
139
Lite Strategy Inc
LITS
$32.4M
$192K 0.02%
+2,227
New +$182K
CTMX icon
140
CytomX Therapeutics
CTMX
$690M
$186K 0.02%
+10,058
New +$229K
CBAY
141
DELISTED
Cymabay Therapeutics
CBAY
$170K 0.02%
+15,367
New +$191K
MRNS
142
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$168K 0.02%
+4,200
New +$120K
ABEO icon
143
Abeona Therapeutics
ABEO
$355M
$162K 0.02%
+507
New +$180K
CLSD
144
DELISTED
Clearside Biomedical
CLSD
$160K 0.02%
+1,731
New +$206K
ATRS
145
DELISTED
Antares Pharma, Inc.
ATRS
$159K 0.02%
+47,280
New +$146K
CYTK icon
146
Cytokinetics
CYTK
$10.6B
$153K 0.02%
+15,582
New +$125K
BDSI
147
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$152K 0.02%
+54,434
New +$153K
IOVA icon
148
Iovance Biotherapeutics
IOVA
$2.04B
$146K 0.02%
+12,957
New +$184K
KDNY
149
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$139K 0.01%
+3,784
New +$121K
QTNT
150
DELISTED
Quotient Limited Ordinary Shares
QTNT
$133K 0.01%
+441
New +$132K
3 4 5
6
7

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM
AAA
AG Asset Advisory Los Angeles, California $121M AUM 10.78% 1-Year Est. Return
TGM
Tenzing Global Management San Francisco, California $121M AUM 85.62% 1-Year Est. Return

Sectoral Asset Management's Q3 2018 Portfolio in Review

As of Q3 2018, Sectoral Asset Management held 174 positions worth $942M, up 5.3% from $894M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Sectoral Asset Management deployed $57.7M of net new capital in Q3 2018, opening 107 new positions and adding to 33 existing holdings. Its largest new stake was Vertex Pharmaceuticals: 76,846 shares worth $14.8M.

By sector, the portfolio is most concentrated in Healthcare at 85% of assets, down from 85% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Sarepta Therapeutics, an estimated $24.4M trimmed.

  • Sectoral Asset Management's largest Q3 2018 buy was Vertex Pharmaceuticals: 76,846 shares worth $14.8M.
  • Sectoral Asset Management added most to Celgene Corp in Q3 2018, an estimated $22.8M increase.
  • Sectoral Asset Management's biggest Q3 2018 reduction was Sarepta Therapeutics, cutting an estimated $24.4M.
  • Sectoral Asset Management fully exited Molina Healthcare in Q3 2018, selling an estimated $17.5M.
  • Sectoral Asset Management's ten largest holdings make up 37% of its $942M portfolio in Q3 2018.
  • Sectoral Asset Management opened 107 new positions and closed 6 in Q3 2018.
  • Sectoral Asset Management's portfolio value rose 5.3% quarter-over-quarter to $942M.

Based on Sectoral Asset Management's 13F filing for Q3 2018, filed 14 Nov 2018.